EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Phytochemical-Based Therapeutic Strategies for Sarcopenia: From Molecular Mechanisms to Clinical Translation

Gengyun Le-Chan iD, Nicole Q Amoah, Hailey M Sofia, Aidan H Quee, Sunny S K Chan iD, Cindy A Thomas-Charles iD

Pharmaceuticals · 07.06.2026 · 19 (6) · 905

DOI: 10.3390/ph19060905 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 07.06.2026. Verfasst von Gengyun Le-Chan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Hillyer College of Arts & Sciences, University of Hartford, 200 Bloomfield Avenue, West Hartford, CT 06117, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Hartford.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sarcopenia is a progressive, age-related musculoskeletal disorder characterized by the loss of skeletal muscle mass, strength, and physical performance, which contributes to frailty, disability, and mortality in older adults. Although resistance exercise and optimized protein intake remain first-line interventions, effective pharmacological therapies are limited, highlighting the need for novel adjunctive strategies. Increasing interest has focused on phytochemicals, plant-derived bioactive compounds with antioxidant, anti-inflammatory, and metabolic regulatory properties that may target multiple mechanisms underlying muscle aging. This review summarizes the molecular and translational potential of phytochemicals in sarcopenia management. Experimental and emerging clinical evidence indicates that flavonoids, polyphenols, alkaloids, and terpenoids modulate key pathways involved in sarcopenia pathogenesis, including PI3K/Akt/mTOR-mediated anabolic signaling, AMPK–SIRT3–PGC-1α-dependent mitochondrial biogenesis, NF-κB-driven inflammation, oxidative stress responses, autophagy, and satellite cell function. Through these pleiotropic effects, phytochemicals may attenuate the anabolic resistance, mitochondrial dysfunction, chronic inflammation, and impaired muscle regeneration associated with aging. Despite promising mechanistic evidence, clinical translation remains limited by poor bioavailability, variability in formulation and dosing, a lack of long-term randomized trials, and inconsistent functional outcome measures. Current evidence suggests that phytochemicals are most effective when integrated with resistance exercise and nutritional support rather than used as stand-alone therapies. Overall, phytochemicals represent promising complementary candidates for sarcopenia prevention and management. Future studies should prioritize standardized formulations, biomarker-guided approaches, and rigorously designed clinical trials focused on clinically meaningful functional outcomes to establish their efficacy, safety, and translational relevance in aging populations.

Schlagwörter

Stichwörter der Autor:innen

agingmusclepharmaceuticalphytochemicalsarcopenia

Autor:innen und Institutionen

  • Department of Biology, Hillyer College of Arts & Sciences, University of Hartford, 200 Bloomfield Avenue, West Hartford, CT 06117, USA.
  • Department of Health Sciences, College of Education, Nursing, and Health Professions, University of Hartford, 200 BloomfieldAvenue, West Hartford, CT 06117, USA.
  • Department of Rehabilitation Sciences, College of Education, Nursing, and Health Professions, University of Hartford, 200 Bloomfield Avenue, West Hartford, CT 06117, USA.
  • Department of Math and Sciences, Connecticut State Community College Norwalk, 188 Richards Avenue, Norwalk, CT 06854, USA.

ORCID-Profile: Gengyun Le-Chan, Sunny S K Chan, Cindy A Thomas-Charles

Förderung

  • University of Hartford

Zitieren

APA

Le-Chan, G., Amoah, N. Q., Sofia, H. M., Quee, A. H., Chan, S. S. K., & Thomas-Charles, C. A. (2026). Phytochemical-Based Therapeutic Strategies for Sarcopenia: From Molecular Mechanisms to Clinical Translation. Pharmaceuticals, 19(6), 905. https://doi.org/10.3390/ph19060905

Vancouver

Le-Chan G, Amoah NQ, Sofia HM, Quee AH, Chan SSK, Thomas-Charles CA. Phytochemical-Based Therapeutic Strategies for Sarcopenia: From Molecular Mechanisms to Clinical Translation. Pharmaceuticals. 2026;19(6):905. doi:10.3390/ph19060905

BibTeX
@article{LeChan2026,
  author = {Le-Chan, Gengyun and Amoah, Nicole Q and Sofia, Hailey M and Quee, Aidan H and Chan, Sunny S K and Thomas-Charles, Cindy A},
  title = {Phytochemical-Based Therapeutic Strategies for Sarcopenia: From Molecular Mechanisms to Clinical Translation},
  journal = {Pharmaceuticals},
  year = {2026},
  volume = {19},
  number = {6},
  pages = {905},
  doi = {10.3390/ph19060905}
}
Kostenlos starten →